The Effect of Cardiovascular Medications on Disease-Related Outcomes in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis

Background: Multiple studies have revealed that idiopathic pulmonary fibrosis (IPF) patients are more at risk for cardiovascular diseases and that many IPF patients receive cardiovascular medications like statins, angiotensin-converting enzyme inhibitor (ACEI), angiotensin receptor blocker (ARB), an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wan-Tong, Wang, Xu-Jie, Xue, Chun-Miao, Ji, Xin-Yu, Pan, Lin, Weng, Wei-Liang, Li, Qiu-Yan, Hua, Guo-Dong, Zhu, Bao-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632524/
https://www.ncbi.nlm.nih.gov/pubmed/34858190
http://dx.doi.org/10.3389/fphar.2021.771804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632524/
https://www.ncbi.nlm.nih.gov/pubmed/34858190
http://dx.doi.org/10.3389/fphar.2021.771804

Ejemplares similares